Haptoglobin genotype and its role in determining heme-iron mediated vascular disease

Pharmacological Research

Volumn 66, Issue 1, 2012, Pages 1-6

  Goldenstein, Hagit ^a   Levy, Nina S ^a   Levy, Andrew P ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Haptoglobin; Hemoglobin; Oxidative Stress; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; APOLIPOPROTEIN A1; CD163 ANTIGEN; HAPTOGLOBIN; HEME; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; IRON; PLACEBO;

BIOACCUMULATION; CARDIOVASCULAR DISEASE; CATALYSIS; COMPLEX FORMATION; CORONARY ARTERY CALCIFICATION; COST CONTROL; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DRUG EFFECT; DRUG MEGADOSE; GENE; GENE STRUCTURE; GENETIC RISK; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE COST; HEART FAILURE; HEART INFARCTION; HP GENE; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; QUALITY OF LIFE; REVIEW; RISK FACTOR; STROKE; VASCULAR DISEASE; VITAMIN SUPPLEMENTATION;

EID: 84860425021     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2012.02.011     Document Type: Article

References (38)

1. A.P. Levy, R. Asleh, S. Blum, N.S. Levy, R. Miller-Lotan, and S. Kalet-Litman Haptoglobin: basic and clinical aspects Antioxid Redox Signal 12 February (2) 2010 293 304
2. M.R. Langlois, and J.R. Delanghe Biological and clinical significance of haptoglobin polymorphism in humans Clin Chem 42 October (10) 1996 1589 1600 (Pubitemid 26354735)
3. R. Asleh, J. Guetta, S. Kalet-Litman, R. Miller-Lotan, and A.P. Levy Haptoglobin genotype- and diabetes-dependent differences in iron-mediated oxidative stress in vitro and in vivo Circ Res 96 March (4) 2005 435 441 (Pubitemid 40354537)
4. M.S. Spagnuolo, L. Cigliano, L.D. D'Andrea, C. Pedone, and P. Abrescia Assignment of the binding site for haptoglobin on apolipoprotein A-I J Biol Chem 280 January (2) 2005 1193 1198
5. R. Asleh, R. Miller-Lotan, M. Aviram, T. Hayek, M. Yulish, and J.E. Levy Haptoglobin genotype is a regulator of reverse cholesterol transport in diabetes in vitro and in vivo Circ Res 99 December (12) 2006 1419 1425 (Pubitemid 44949678)
6. M. Balestrieri, L. Cigliano, M.L. Simone, B. Dale, and P. Abrescia Haptoglobin inhibits lecithin-cholesterol acyltransferase in human ovarian follicular fluid Mol Reprod Dev 59 June (2) 2001 186 191 (Pubitemid 32391244)
7. F.M. Nakhoul, R. Zoabi, Y. Kanter, M. Zoabi, K. Skorecki, and I. Hochberg Haptoglobin phenotype and diabetic nephropathy Diabetologia 44 May (5) 2001 602 604 (Pubitemid 32411276)
8. A.P. Levy, A. Roguin, I. Hochberg, P. Herer, S. Marsh, and F.M. Nakhoul Haptoglobin phenotype and vascular complications in patients with diabetes N Engl J Med 343 September (13) 2000 969 970
9. A. Roguin, I. Hochberg, E. Nikolsky, W. Markiewicz, S.R. Meisel, and J. Hir Haptoglobin phenotype as a predictor of restenosis after percutaneous transluminal coronary angioplasty Am J Cardiol 87 February (3) 2001 330
10. A.P. Levy, I. Hochberg, K. Jablonski, H.E. Resnick, E.T. Lee, and L. Best Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: the strong heart study J Am Coll Cardiol 40 December (11) 2002 1984 1990 (Pubitemid 35425366)
11. A. Roguin, W. Koch, A. Kastrati, D. Aronson, A. Schomig, and A.P. Levy Haptoglobin genotype is predictive of major adverse cardiac events in the 1-year period after percutaneous transluminal coronary angioplasty in individuals with diabetes Diabetes Care 26 September (9) 2003 2628 2631 (Pubitemid 37052111)
12. M. Suleiman, D. Aronson, R. Asleh, M.R. Kapeliovich, A. Roguin, and S.R. Meisel Haptoglobin polymorphism predicts 30-day mortality and heart failure in patients with diabetes and acute myocardial infarction Diabetes 54 September (9) 2005 2802 2806 (Pubitemid 41233605)
13. U. Milman, S. Blum, C. Shapira, D. Aronson, R. Miller-Lotan, and Y. Anbinder Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial Arterioscler Thromb Vasc Biol 28 February (2) 2008 341 347 (Pubitemid 351161209)
14. T. Costacou, R.E. Ferrell, and T.J. Orchard Haptoglobin genotype: a determinant of cardiovascular complication risk in type 1 diabetes Diabetes 57 June (6) 2008 1702 1706
15. M. Simpson, J.K. Snell-Bergeon, G.L. Kinney, O. Lache, R. Miller-Lotan, and Y. Anbinder Haptoglobin genotype predicts development of coronary artery calcification in a prospective cohort of patients with type 1 diabetes Cardiovasc Diabetol 10 November 2011 99
16. T. Costacou, R.E. Ferrell, D. Ellis, and T.J. Orchard Haptoglobin genotype and renal function decline in type 1 diabetes Diabetes 58 December (12) 2009 2904 2909
17. R. Miller-Lotan, Y. Herskowitz, S. Kalet-Litman, F. Nakhoul, D. Aronson, and R. Zoabi Increased renal hypertrophy in diabetic mice genetically modified at the haptoglobin locus Diabetes Metab Res Rev 21 July-August (4) 2005 332 337 (Pubitemid 40945954)
18. R. Asaf, S. Blum, A. Roguin, S. Kalet-Litman, J. Kheir, and A. Frisch Haptoglobin genotype is a determinant of survival and cardiac remodeling after myocardial infarction in diabetic mice Cardiovasc Diabetol 8 June 2009 29
19. A.P. Levy, J.E. Levy, S. Kalet-Litman, R. Miller-Lotan, N.S. Levy, and R. Asaf Haptoglobin genotype is a determinant of iron, lipid peroxidation, and macrophage accumulation in the atherosclerotic plaque Arterioscler Thromb Vasc Biol 27 January (1) 2007 134 140 (Pubitemid 46360390)
20. S.M. Sadrzadeh, E. Graf, S.S. Panter, P.E. Hallaway, and J.W. Eaton Hemoglobin A biologic fenton reagent J Biol Chem 259 December (23) 1984 14354 14356
21. J.M. Rifkind, S. Ramasamy, P.T. Manoharan, E. Nagababu, and J.G. Mohanty Redox reactions of hemoglobin Antioxid Redox Signal 6 June (3) 2004 657 666 (Pubitemid 38625386)
22. J.D. Belcher, J.D. Beckman, G. Balla, J. Balla, and G. Vercellotti Heme degradation and vascular injury Antioxid Redox Signal 12 February (2) 2010 233 248
23. H.F. Bunn, and J.H. Jandl Exchange of heme among hemoglobin molecules Proc Natl Acad Sci USA 56 September (3) 1966 974 978
24. M. Melamed-Frank, O. Lache, B.I. Enav, T. Szafranek, N.S. Levy, and R.M. Ricklis Structure-function analysis of the antioxidant properties of haptoglobin Blood 98 December (13) 2001 3693 3698
25. V.V. Bamm, V.A. Tsemakhovich, M. Shaklai, and N. Shaklai Haptoglobin phenotypes differ in their ability to inhibit heme transfer from hemoglobin to LDL Biochemistry 43 April (13) 2004 3899 3906 (Pubitemid 38437056)
26. Z. Wu, M.A. Wagner, L. Zheng, J.S. Parks, J.M. Shy 3rd, and J.D. Smith The refined structure of nascent HDL reveals a key functional domain for particle maturation and dysfunction Nat Struct Mol Biol 14 September (9) 2007 861 868 (Pubitemid 47373831)
27. M. Navab, G.M. Anantharamaiah, S.T. Reddy, B.J. Van Lenten, B.J. Ansell, and A.M. Fogelman Mechanisms of disease: Proatherogenic HDL - an evolving field Nat Clin Pract Endocrinol Metab 2 September (9) 2006 504 511 (Pubitemid 44353291)
28. A.P. Levy, K.R. Purushothaman, N.S. Levy, M. Purushothaman, M. Strauss, and R. Asleh Downregulation of the hemoglobin scavenger receptor in individuals with diabetes and the hp 2-2 genotype: implications for the response to intraplaque hemorrhage and plaque vulnerability Circ Res 101 July (1) 2007 106 110 (Pubitemid 47094629)
29. R. Asleh, S. Blum, S. Kalet-Litman, J. Alshiek, R. Miller-Lotan, and R. Asaf Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotype Diabetes 57 October (10) 2008 2794 2800
30. P.R. Moreno, K.R. Purushothaman, M. Purushothaman, P. Muntner, N.S. Levy, and V. Fuster Haptoglobin genotype is a major determinant of the amount of iron in the human atherosclerotic plaque J Am Coll Cardiol 52 September (13) 2008 1049 1051
31. C. Lioupis, C. Barbatis, A. Drougou, V. Koliaraki, A. Mamalaki, and C. Klonaris Association of haptoglobin genotype and common cardiovascular risk factors with the amount of iron in atherosclerotic carotid plaques Atherosclerosis 216 May (1) 2011 131 138
32. E.B. Rimm, M.J. Stampfer, A. Ascherio, E. Giovannucci, G.A. Colditz, and W.C. Willett Vitamin E consumption and the risk of coronary heart disease in men N Engl J Med 328 May (20) 1993 1450 1456 (Pubitemid 23143847)
33. E.R. Miller 3rd, R. Pastor-Barriuso, D. Dalal, R.A. Riemersma, L.J. Appel, and E. Guallar Meta-analysis. High-dosage vitamin E supplementation may increase all-cause mortality Ann Intern Med 142 January (1) 2005 37 46
34. S. Blum, M. Vardi, N.S. Levy, R. Miller-Lotan, and A.P. Levy The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes Atherosclerosis 211 July (1) 2010 25 27
35. S. Yusuf, G. Dagenais, J. Pogue, J. Bosch, and P. Sleight Vitamin E supplementation and cardiovascular events in high-risk patients the heart outcomes prevention evaluation study investigators N Engl J Med 342 January (3) 2000 154 160 (Pubitemid 30051646)
36. A.P. Levy, H.C. Gerstein, R. Miller-Lotan, R. Ratner, M. McQueen, and E. Lonn The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes Diabetes Care 27 November (11) 2004 2767 (Pubitemid 39441487)
37. D. Farbstein, S. Blum, M. Pollak, R. Asaf, H.L. Viener, and O. Lache Vitamin E therapy results in a reduction in HDL function in individuals with diabetes and the haptoglobin 2-1 genotype Atherosclerosis 219 November (1) 2011 240 244
38. F.M. Nakhoul, R. Miller-Lotan, H. Awad, R. Asleh, K. Jad, and N. Nakhoul Pharmacogenomic effect of vitamin E on kidney structure and function in transgenic mice with the haptoglobin 2-2 genotype and diabetes mellitus Am J Physiol Renal Physiol 296 April (4) 2009 F830 F838